Daily Emollients Reduce Atopic Dermatitis in Infants
Emollients Show Promise in Preventing Eczema in Infants, Study Finds
Table of Contents
New Research highlights the protective Power of Early Emollient Use
A groundbreaking study published in JAMA Dermatology suggests that consistent, full-body emollient application starting in the first two months of life can significantly reduce the risk of atopic dermatitis (AD) in infants. This research offers valuable insights for parents and healthcare providers seeking effective strategies for infant skin health and eczema prevention.
Key Findings from the Randomized Clinical Trial
The trial, wich included 1247 infants, revealed compelling results regarding the efficacy of daily moisturizer use. At the 24-month mark, infants in the daily moisturizer group experienced a cumulative incidence of AD of 36.1%, compared to 43.0% in the control group. This translates to a relative risk (RR) of 0.84 (95% CI, 0.73-0.97), indicating a statistically meaningful reduction in AD progress (P = .02).
The protective effect of emollients was even more pronounced in infants not considered at high risk for AD. In this subgroup, the RR was 0.75 (95% CI,0.60-0.90; P = .01), suggesting that early emollient use can be a powerful preventative measure for a broader population.
Factors Influencing Emollient Efficacy
The study also explored how certain factors might modify the effectiveness of emollient therapy. While the interaction between having a first-degree blood relative with atopic disease and emollient use was not statistically significant, a notable difference was observed based on the presence of pets in the household.
Infants in households with a dog experienced a stronger protective effect from the intervention. The risk difference (RD) was -14.2 (95% CI, -23.2 to -4.6) in this group. Conversely, infants in homes without pets showed a less pronounced effect (RD, 0.3; 95% CI, -9.6 to 10.3), though this difference was not statistically significant. These findings suggest a potential interplay between environmental factors and emollient efficacy.
Secondary Outcomes and Future Directions
Beyond AD prevention, the study also examined the incidence of skin infections as a secondary outcome. While the daily moisturizer group had slightly lower rates of skin infections (19.8%) compared to the control group (21.1%), the difference was not statistically significant (RR, 0.94; 95% CI, 0.74-1.20).
The research team emphasized that routine emollient use is already a common practice for many families in the US,with 64% of participants reporting using emollients before the study. This suggests that integrating emollient therapy into standard infant skincare routines could be a practical and effective approach.
The authors noted that the specific composition of emollients,such as the presence of ceramides,may influence their efficacy,warranting further inquiry into different moisturizer formulations.
Looking ahead, the researchers highlighted the need for further studies to assess the cost-effectiveness and implementation strategies for emollient therapy.Additionally, understanding the impact of this approach on allergic comorbidities remains a high priority for future research.
this study provides robust evidence that early and consistent emollient application can be a valuable tool in preventing the development of atopic dermatitis in infants, especially for those with a family history of AD and in households with dogs.
References:
- Simpson EL, Michaels LC, ramsey K, et al. Emollients to Prevent pediatric Eczema: A Randomized Clinical Trial. JAMA Dermatol. Published online July 23, 2025. doi:10.1001/jamadermatol.2025.2357
- Fitch J.Atopic dermatitis phenotypes and allergic disease development in children. July 25, 2025. accessed July 28, 2025. https://www.contemporarypediatrics.com/view/atopic-dermatitis-phenotypes-and-allergic-disease-development-in-children